Additionally, NRF2 also regulates the expression of the solute carrier family 7 member 11 (SLC7A11), which encodes the cystine/glutamate transporter XCT [23]
Patients with well-managed hypothyroidism on stable levothyroxine replacement can generally proceed with GLP-1 therapy if clinically indicated
tb or BCG to generate in vitro granulomas to determine whether in vivo L-GSH supplementation improved immune responses against mycobacterial infection
GLP-1 receptor agonists, including the blockbuster drugs semaglutide and tirzepatide, are increasingly being prescribed to patients with type 1 diabetes, despite having no FDA approval for this indication, according to a study published Wednesday in the Journal of the American Medical Association
Frequently Asked Questions What is the BPC-157 TB-500 blend used for in preclinical research
Clinical Update 11/08/2022 Potassium Added to Starbucks Coffee